11va Conferencia de Cannabinoides en medicina de IACM // cDMX
5-6-7 NOV 2020

En años recientes los países latinoamericanos han avanzado hacia la regulación del Cannabis medicinal. Mexico está por convertirse en el nuevo país que tendrá medicina cannábica regulada para Julio del 2020.

Días
Horas
Minutos
Segundos

About the event

Due to the global situation caused to the COVID19 pandemic, affecting traveling and large gatherings, the IACM and the AMMCann as organizers of the 11th Conference on Cannabinoids in Medicine in Mexico City, we have made the following determinations:

* The Conference is being planned for the time being in a face-to-face / virtual hybrid modality. This means that some speakers will present their work from remote locations, but also that the conference can be seen in its entirety through the event’s platform. (Limited to xxx virtual tickets).

* If the situation from COVID19 doesn’t allow for large gatherings or safe travels into México in November, the whole Conference will be held virtually and streamed to all participants.

* The venue of the face-to-face event at CDMX is the National Institute of Genomic Medicine, INMEGEN, on November 5, 6 and 7, 2020. The auditorium has capacity for 450 people.

* The virtual venue will be the platform for the event ———-. Through it you will be able to watch the live streaming of all the speakers and a virtual gallery of the works presented in poster form.

* As it is a tradition at IACM events, a Call for Scientific Papers has been issued, which may be selected for oral or poster presentation. This call is addressed especially to Mexican and Latin American scientists, as this is an invaluable opportunity to present their work and forge collaborative ties with the international Cannabinoid Based Medicine community, represented by the IACM.

PONENTES

Donald Abrams

Donald I. Abrams, MD. is an oncologist at Zuckerberg San Francisco General and a Professor of Clinical Medicine at the University of California …

QFI. Alionka Citlali P. Ángeles Moreno egresada de la Escuela Nacional de Ciencias Biológicas del IPN. Ha trabajado en …

Médico integrativo, graduada de de la Universidad del Rosario en Colombia,  yposgrado del Canadian College of Naturopathic…

Francisco Guimarães graduated in Medicine in 1981 and obtained his PhD in Pharmacology at the Medical School of …

Franjo Grotenhermen completed his medical studies and received his doctorate (M. D.) in Cologne. His fields …

Manuel Guzmán

Manuel Guzmán es profesor de bioquímica y biología molecular en la Universidad Complutense de Madrid. Durante los últimos 25 años …

Médico Cirujano egresado de la Universidad Autónoma del Estado de Hidalgo. 2000-2006. Médico Especialis…

Considerado el padre de la Medicina Basada en Cannabinoides por sus innumerables contribuciones …

Mueller-Vahl

Dr. Kirsten Müller-Vahl, M.D., is a Professor of Psychiatry at the Department of Psychiatry, Socialpsychiatry and Psychotherapy at the …

Eric Murillo

El profesor Eric Murillo-Rodríguez es psicólogo y tiene un doctorado en ciencias biomédicas, ambos títulos académicos obtenidos por la …

Roger Pertwee

Roger Pertwee MA, D.Phil. DSc. (Oxford) is an Emeritus Professor at the University of Aberdeen, still actively engaged in cannabinoid …

Médico Cirujano, Maestro en Psicología, Dr. En
Neurociencias y Terapeuta Cognitivo Conductual. Fue PosDoctoral Fellow en la Facultad …

Doctora en Medicina de la Facultad de Medicina de la Universidad de la República de Uruguay, especialista en Endocannabinología …

Dr. Sari Prutchi Sagiv has over 15 years of experience in various aspects of pharmaceutical development including discovery…

Contáctanos

Teléfono 5571599726
Email: info@ammcann.org
LUN-VIE 09:00 - 17:00